Monitoring the Intracellular Fate of Molecular Beacons : The Challenge of False Positive Signals
(2024) In Advanced NanoBiomed Research- Abstract
Molecular beacons (MBs) have been used on surfaces for detecting oligonucleotides. Attempts to use them intracellularly for monitoring mRNA content have been made, however, without any clear conclusion regarding the reliability of the method, mainly due to false positive signals. To reach an understanding of the intracellular fate of MBs, a critical question remains: how long after MB delivery and where in the cell does a false positive signal appear? To answer that question, the MB delivery method should allow for a time-stamped synchronized delivery of MBs to multiple cells, resulting in MBs being distributed in the cytosol immediately after delivery. Herein, nanostraws are used to inject MBs targeting insulin (Ins1) mRNA directly in... (More)
Molecular beacons (MBs) have been used on surfaces for detecting oligonucleotides. Attempts to use them intracellularly for monitoring mRNA content have been made, however, without any clear conclusion regarding the reliability of the method, mainly due to false positive signals. To reach an understanding of the intracellular fate of MBs, a critical question remains: how long after MB delivery and where in the cell does a false positive signal appear? To answer that question, the MB delivery method should allow for a time-stamped synchronized delivery of MBs to multiple cells, resulting in MBs being distributed in the cytosol immediately after delivery. Herein, nanostraws are used to inject MBs targeting insulin (Ins1) mRNA directly in the cytosol of clonal beta-cells, and the evolution of the MB fluorescence in time and space is monitored. The results show an MB translocation to the nucleus, where MBs are degraded or where they open nonspecifically, before the fluorophore alone is expelled back from the nucleus to the cytosol. The signal translocation to the nucleus and back to the cytosol is faster when scrambled MBs are used. The results shed light on the intracellular fate of MBs and highlight the short time scales before false positive signals become predominant.
(Less)
- author
- Volpati, Diogo LU ; Aoki, Pedro H.B. LU ; Johansson, Therese B. LU ; Munita, Roberto LU ; Ekstrand, Frida LU ; Ruhrmann, Sabrina LU ; Bacos, Karl LU ; Ling, Charlotte LU and Prinz, Christelle N. LU
- organization
-
- Solid State Physics
- NanoLund: Centre for Nanoscience
- LTH Profile Area: Nanoscience and Semiconductor Technology
- LU Profile Area: Light and Materials
- LTH Profile Area: Engineering Health
- Division of Molecular Hematology (DMH)
- Diabetes - Epigenetics (research group)
- EXODIAB: Excellence of Diabetes Research in Sweden
- EpiHealth: Epidemiology for Health
- LUCC: Lund University Cancer Centre
- publishing date
- 2024
- type
- Contribution to journal
- publication status
- epub
- subject
- keywords
- beta-cells, cell interrogation, live cell imaging, molecular beacons, nanostraws
- in
- Advanced NanoBiomed Research
- publisher
- Wiley
- external identifiers
-
- scopus:85186901810
- ISSN
- 2699-9307
- DOI
- 10.1002/anbr.202300147
- language
- English
- LU publication?
- yes
- id
- 22d0bf2d-984d-4c2f-afc0-1600c966fe29
- date added to LUP
- 2024-04-02 15:35:23
- date last changed
- 2024-04-02 15:35:49
@article{22d0bf2d-984d-4c2f-afc0-1600c966fe29, abstract = {{<p>Molecular beacons (MBs) have been used on surfaces for detecting oligonucleotides. Attempts to use them intracellularly for monitoring mRNA content have been made, however, without any clear conclusion regarding the reliability of the method, mainly due to false positive signals. To reach an understanding of the intracellular fate of MBs, a critical question remains: how long after MB delivery and where in the cell does a false positive signal appear? To answer that question, the MB delivery method should allow for a time-stamped synchronized delivery of MBs to multiple cells, resulting in MBs being distributed in the cytosol immediately after delivery. Herein, nanostraws are used to inject MBs targeting insulin (Ins1) mRNA directly in the cytosol of clonal beta-cells, and the evolution of the MB fluorescence in time and space is monitored. The results show an MB translocation to the nucleus, where MBs are degraded or where they open nonspecifically, before the fluorophore alone is expelled back from the nucleus to the cytosol. The signal translocation to the nucleus and back to the cytosol is faster when scrambled MBs are used. The results shed light on the intracellular fate of MBs and highlight the short time scales before false positive signals become predominant.</p>}}, author = {{Volpati, Diogo and Aoki, Pedro H.B. and Johansson, Therese B. and Munita, Roberto and Ekstrand, Frida and Ruhrmann, Sabrina and Bacos, Karl and Ling, Charlotte and Prinz, Christelle N.}}, issn = {{2699-9307}}, keywords = {{beta-cells; cell interrogation; live cell imaging; molecular beacons; nanostraws}}, language = {{eng}}, publisher = {{Wiley}}, series = {{Advanced NanoBiomed Research}}, title = {{Monitoring the Intracellular Fate of Molecular Beacons : The Challenge of False Positive Signals}}, url = {{http://dx.doi.org/10.1002/anbr.202300147}}, doi = {{10.1002/anbr.202300147}}, year = {{2024}}, }